Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
7.01
-0.29 (-3.97%)
At close: Jan 2, 2026, 4:00 PM EST
7.00
-0.01 (-0.14%)
After-hours: Jan 2, 2026, 6:34 PM EST
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of $29.23 million as of January 2, 2026. Its market cap has increased by 251.64% in one year.
Market Cap
29.23M
Enterprise Value
29.56M
1-Year Change
251.64%
Ranking
Category
Stock Price
$7.01
Market Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from $121.65M to $29.23M, a decrease of -75.97%. That is a compound annual growth rate of -17.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 29.23M | 319.74% |
| Dec 31, 2024 | 6.96M | -80.54% |
| Dec 29, 2023 | 35.78M | 20.93% |
| Dec 30, 2022 | 29.59M | -29.85% |
| Dec 31, 2021 | 42.18M | 40.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |